Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2026
Adaptive feedback signaling via the FAK/SRC pathway promotes KRAS G12C inhibitor resistanceHibiki Udagawa, Yuji Shibata, Monique B Nilsson, et al.
Cancer Research|May 2, 2019
LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung AdenocarcinomaAna Galan-Cobo, Piyada Sitthideatphaiboon, Xiao Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase InhibitionPiyada Sitthideatphaiboon, Ana Galan-Cobo, Marcelo V Negrao, et al.
Molecular Cancer Research : MCR|October 16, 2021
Enhanced Vulnerability of LKB1-Deficient NSCLC to Disruption of ATP Pools and Redox Homeostasis by 8-Cl-AdoAna Galan-Cobo, Christine M Stellrecht, Emrullah Yilmaz, et al.
The Journal of Molecular Diagnostics : JMD|July 30, 2026
Analytical Validation of a Plasma-Based Rapid Liquid Biopsy Assay Using Next-Generation SequencingSinchita Roy-Chowdhuri, Ana Galan-Cobo, Nitin Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLCNatalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, et al.
Cancer Cell|June 16, 2023
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinomaYu Qian, Ana Galan-Cobo, Irene Guijarro, et al.
Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.
Cancer Discovery|May 19, 2018
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung AdenocarcinomaFerdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Nature|October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Pageof 1